Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Journal of Opioid Management|January 6, 2016
Pain intensity and interference with functioning and well-being in subgroups of patients with chronic pain treated with once-daily hydrocodone tabletsAdrian Bartoli, Edward Michna, Ellie He, et al.
Postgraduate Medicine|December 20, 2014
Efficacy and safety of once-daily, extended-release hydrocodone in individuals previously receiving hydrocodone/acetaminophen combination therapy for chronic painAdrian Bartoli, Edward Michna, Ellie He, et al.
The New England Journal of Medicine|November 9, 2019
A Phase 3 Trial of Difelikefalin in Hemodialysis Patients with PruritusSteven Fishbane, Aamir Jamal, Catherine Munera, et al.
Journal of Opioid Management|August 28, 2015
12-Month safety and effectiveness of once-daily hydrocodone tablets formulated with abuse-deterrent properties in patients with moderate to severe chronic painWarren Wen, Louise Taber, Shau Yu Lynch, et al.
Expert Opinion on Pharmacotherapy|June 27, 2015
A multicenter, randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of single-entity, once-daily hydrocodone tablets in patients with uncontrolled moderate to severe chronic low back painWarren Wen, Steve Sitar, Shau Yu Lynch, et al.
Geriatric Nursing (New York, N.Y.)|August 10, 2016
Long-term effectiveness and safety of once-daily, single-entity, extended-release hydrocodone in patients of ≥75 years of age with moderate to severe nonmalignant and nonneuropathic painKathleen Broglio, Joseph Pergolizzi, Maribeth Kowalski, et al.
Expert Opinion on Pharmacotherapy|March 14, 2012
A randomized, 14-day, double-blind study evaluating conversion from hydrocodone/acetaminophen (Vicodin) to buprenorphine transdermal system 10 μg/h or 20 μg/h in patients with osteoarthritis painSteven R Ripa, Bill H McCarberg, Catherine Munera, et al.
Journal of Renal Care|May 6, 2025
Influence of Baseline Itch Severity on Treatment Outcomes With Difelikefalin in Adults With Moderate-to-Severe Pruritus Receiving Maintenance Haemodialysis: An Exploratory AnalysisKieran McCafferty, Thilo Schaufler, Pablo Molina, et al.
Pain Practice : the Official Journal of World Institute of Pain|June 19, 2016
Efficacy and Safety of Once-Daily Extended-Release (ER) Hydrocodone in Individuals Previously Receiving ER Morphine for Chronic PainKathleen Broglio, Joseph Pergolizzi, Maribeth Kowalski, et al.
Expert Opinion on Drug Safety|March 20, 2013
Application site adverse events associated with the buprenorphine transdermal system: a pooled analysisWarren Wen, Shau Yu Lynch, Catherine Munera, et al.
Pageof 4